XML 42 R25.htm IDEA: XBRL DOCUMENT v3.25.3
Fair Value Measurements (Tables)
9 Months Ended
Sep. 30, 2025
Fair Value Disclosures [Abstract]  
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis
The following tables present the Company's financial assets and liabilities measured at fair value on a recurring basis and their assigned levels within the fair value hierarchy (in thousands):
September 30, 2025
Level 1Level 2Level 3Total
Money market funds(1)
$6,189 $— $— $6,189 
Total assets$6,189 $— $— $6,189 
Warrant liabilities
$— $3,872 $$3,877 
Total liabilities$— $3,872 $$3,877 
December 31, 2024
Level 1 Level 2Level 3Total
Money market funds(1)
$12,100 $— $— $12,100 
Total assets
$12,100 $— $— $12,100 
Warrant liabilities
$— $2,827 $$2,828 
Total liabilities
$— $2,827 $$2,828 
_________________
(1) Included in cash, cash equivalents, and restricted cash on the condensed consolidated balance sheets. This balance includes cash requirements settled on a nightly basis.
Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation The following table presents a summary of changes in Level 3 in the fair value of the Company’s common stock warrant liability (in thousands):
For the nine months ended,
For the year ended,
September 30,
2025
December 31,
2024
Balance, beginning of the period$$11 
Change in fair value(10)
Balance, end of the period$$
Schedule of Fair Value Measurement Inputs and Valuation Techniques
The fair value of the assumed Angion Warrant liability was estimated using the following assumptions:
September 30,
2025
December 31,
2024
Weighted average strike price$76.00$76.00
Contractual term (years)
2.93.7
Volatility (annual)
80.3 %74.9 %
Risk-free rate
3.8 %4.4 %
Dividend yield (per share)
— %— %